Middle East and Africa Ventricular Assist Device Market

1.Executive Summary

2.Introduction
   2.1.Study Objectives
   2.2.Market Definition
         2.2.1.Market Covered
         2.2.2.Geographical Coverage
         2.2.3.Study Years & Currency
   2.3.Market Stakeholders
   2.4.Key Questions this Study will Answer
   2.5.GMI Research’s Approach & Methodology

3.Middle East and Africa Ventricular Assist Device Market - Overview
   3.1.Introduction
   3.2.Market Segmentation
   3.3.Value Chain Analysis
   3.4.Drivers
   3.5.Restraints
   3.6.Trends

4.Middle East and Africa Ventricular Assist Device Market Revenue Forecast till 2025

5.Middle East and Africa Ventricular Assist Device Market by Type Revenue Forecast till 2025
   5.1.Left Ventricular
   5.2.Right Ventricular
   5.3.Biventricular Assist Device

6.Middle East and Africa Ventricular Assist Device Market by Application Revenue Forecast till 2025.
   6.1.Bridge-to-transplant (BTT) Therapy
   6.2.Destination Therapy
   6.3.Bridge-to-recovery (BTR) Therapy

7.Middle East and Africa Ventricular Assist Device Market by Design Revenue Forecast till 2025
   7.1.Implantable Device
   7.2.Transcutaneous Device

8.Middle East and Africa Ventricular Assist Device Market by Country Revenue Forecast till 2025
   8.1.U.A.E. Market Revenue Forecast till 2025.
         8.1.1. U.A.E. Market by Type (Option 1: 25% customization)
                   8.1.1.1.Left Ventricular
                   8.1.1.2.Right Ventricular
                   8.1.1.3.Biventricular Assist Device
         8.1.2. U.A.E. VAD Market by Application.
                   8.1.2.1.Bridge-to-transplant (BTT) Therapy
                   8.1.2.2.Destination Therapy
                   8.1.2.3.Bridge-to-recovery (BTR) Therapy
         8.1.3. U.A.E. VAD Market by Design.
                   8.1.3.1.Implantable Device
                   8.1.3.2.Transcutaneous Device

   8.2.Saudi Arabia VAD Market Revenue Forecast till 2025.
         8.2.1. Saudi Arabia VAD Market by Type (Option 2: 25% customization)
                   8.2.1.1.Left Ventricular
                   8.2.1.2.Right Ventricular
                   8.2.1.3.Biventricular Assist Device
         8.2.2. Saudi Arabia VAD Market by Application Type.
                   8.2.2.1.Bridge-to-transplant (BTT) Therapy
                   8.2.2.2.Destination Therapy
                   8.2.2.3.Bridge-to-recovery (BTR) Therapy
         8.2.3. Saudi Arabia VAD Market by Design.
                   8.2.3.1.Implantable Device
                   8.2.3.2.Transcutaneous Device

   8.3.Oman VAD Market Revenue Forecast till 2025.
         8.3.1. Oman VAD Market by Type (Option 3: 25% customization)
                   8.3.1.1.Left Ventricular
                   8.3.1.2.Right Ventricular
                   8.3.1.3.Biventricular Assist Device
         8.3.2. Oman VAD Market by Application.
                   8.3.2.1.Bridge-to-transplant (BTT) Therapy
                   8.3.2.2.Destination Therapy
                   8.3.2.3.Bridge-to-recovery (BTR) Therapy
         8.3.3. Oman VAD Market by Design.
                   8.3.3.1.Implantable Device
                   8.3.3.2.Transcutaneous Device

   8.4.South Africa Ventricular Assist Device Market Revenue Forecast till 2025
         8.4.1. South Africa Ventricular Assist Device Market by Type (Option 4: 25% customization)
                   8.4.1.1.Left Ventricular
                   8.4.1.2.Right Ventricular
                   8.4.1.3.Biventricular Assist Device
         8.4.2. South Africa Ventricular Assist Device Market by Application.
                   8.4.2.1.Bridge-to-transplant (BTT) Therapy
                   8.4.2.2.Destination Therapy
                   8.4.2.3.Bridge-to-recovery (BTR) Therapy
         8.4.3. South Africa Ventricular Assist Device Market by Design.
                   8.4.3.1.Implantable Device
                   8.4.3.2.Transcutaneous Device

   8.5.Nigeria Ventricular Assist Device Market Revenue Forecast till 2025
         8.5.1. Nigeria Ventricular Assist Device Market by Type (Option 5: 25% customization)
                   8.5.1.1.Left Ventricular
                   8.5.1.2.Right Ventricular
                   8.5.1.3.Biventricular Assist Device
         8.5.2. Nigeria Ventricular Assist Device Market by Application.
                   8.5.2.1.Bridge-to-transplant (BTT) Therapy
                   8.5.2.2.Destination Therapy
                   8.5.2.3.Bridge-to-recovery (BTR) Therapy
         8.5.3. Nigeria Ventricular Assist Device Market by Design.
                   8.5.3.1.Implantable Device
                   8.5.3.2.Transcutaneous Device

   8.6.Egypt Ventricular Assist Device Market Revenue Forecast till 2025
         8.6.1. Egypt Ventricular Assist Device Market by Type (Option 6: 25% customization)
                   8.6.1.1.Left Ventricular
                   8.6.1.2.Right Ventricular
                   8.6.1.3.Biventricular Assist Device
         8.6.2. Egypt Ventricular Assist Device Market by Application.
                   8.6.2.1.Bridge-to-transplant (BTT) Therapy
                   8.6.2.2.Destination Therapy
                   8.6.2.3.Bridge-to-recovery (BTR) Therapy
         8.6.3. Egypt Ventricular Assist Device Market by Design.
                   8.6.3.1.Implantable Device
                   8.6.3.2.Transcutaneous Device

   8.7.Rest of Middle East and Africa Ventricular Assist Device Market Revenue Forecast till 2025
         8.7.1. Rest of Middle East and Africa Ventricular Assist Device Market by Type (Option 5: 25% customization)
                   8.7.1.1.Left Ventricular
                   8.7.1.2.Right Ventricular
                   8.7.1.3.Biventricular Assist Device
         8.7.2. Rest of Middle East and Africa Ventricular Assist Device Market by Application.
                   8.7.2.1.Bridge-to-transplant (BTT) Therapy
                   8.7.2.2.Destination Therapy
                   8.7.2.3.Bridge-to-recovery (BTR) Therapy
         8.7.3. Rest of Middle East and Africa Ventricular Assist Device Market by Design.
                   8.7.3.1.Implantable Device
                   8.7.3.2.Transcutaneous Device

9.Competitive Landscape
   9.1.Industry Attractiveness
   9.2.Porter 5 Analysis
   9.3.Major players and their key strategies
   9.4.Company Share Analysis

10.Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
     10.1. Berlin heart GmbH
              10.1.1.Company Overview
              10.1.2.Financials
              10.1.3.Recent Developments

     10.2.Cardiac Assist, Inc. (LivaNova)
              10.2.1.Company Overview
              10.2.2.Financials
              10.2.3.Recent Developments

     10.3. HeartWare International, Inc.
              10.3.1.Company Overview
              10.3.2.Financials
              10.3.3.Recent Developments

     10.4.Jarvik heart, Inc.
              10.4.1.Company Overview
              10.4.2.Financials
              10.4.3.Recent Developments

     10.5. Reliant Heart, Inc.
              10.5.1.Company Overview
              10.5.2.Financials
              10.5.3.Recent Developments

     10.6. Abbott
              10.6.1.Company Overview
              10.6.2.Financials
              10.6.3.Recent Developments

     10.7. Sun Medical Technology Research Corp.
              10.7.1.Company Overview
              10.7.2.Financials
              10.7.3.Recent Developments

     10.8. Syncardia System, Inc.
              10.8.1.Company Overview
              10.8.2.Financials
              10.8.3.Recent Developments

     10.9.Thoratec Corporation
              10.9.1.Company Overview
              10.9.2.Financials
              10.9.3.Recent Developments

     10.10. Abiomed
              10.10.1.Company Overview
              10.10.2.Financials
              10.10.3.Recent Developments

11.About GMI Research